Navigation Links
Kendle to Present at the 2008 Credit Suisse Health Care Conference
Date:11/11/2008

CINCINNATI, Nov. 11 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) a leading, global full-service clinical research organization, today announced Senior Vice President and Chief Financial Officer Karl "Buzz" Brenkert III will participate in the annual Credit Suisse Health Care Conference. The conference will be held at the Arizona Biltmore Resort & Spa in Phoenix, Nov. 11-14, 2008. Kendle's presentation is scheduled for Friday, Nov. 14 at 10 a.m. Mountain Time (12 p.m. Eastern Standard Time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )

The public is invited to listen to a live Webcast of Kendle's presentation at http://www.kendle.com (click on the link provided in the Investor Events and Presentations section). An archived version can be accessed approximately three hours following Kendle's presentation and will be available until Dec. 15. Slides accompanying the presentation will be available by 9:00 a.m. Eastern Standard Time on Nov. 14 at http://www.kendle.com under the Investor Events and Presentations section.
Following is a direct link to the Credit Suisse Webcast:

http://w.on24.com/r.htm?e=125759&s=1&k=C0D3FF705148BDBB6A63AEE79C3E2912

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Kendle was recognized by FORTUNE magazine as one of the 100 fastest-growing companies in the United States for 2008. The company also has been recognized as "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
2. Kendle Named a Best Place to Work in Greater Cincinnati
3. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
4. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast
7. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
8. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
9. Kendle Appoints Patricia Williams Vice President, Commercial Operations
10. Kendle Invites You to Attend its First Quarter 2008 Earnings Conference Call and Webcast
11. Kendle to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology:
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext Inc., a global ... of a media edge server, the M820, which features the company,s ... recognition software provided by Tera Probe, Inc., will be showcased during ... at the NAB show at the Las Vegas ... ...
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
Breaking Biology News(10 mins):